Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Tongue Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Pleural Effusion, Malignant 1Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myeloid, Acute 1Breast Neoplasms 1Anus Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1Anal Canal Carcinoma 1Adenocarcinoma of Lung 1

Interventions

Fluorouracil 8Cisplatin 5Radiotherapy 4Mitomycin 4Light Coagulation 3dehydroftorafur 2Watchful Waiting 2Taxes 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Cetuximab 2Carboplatin 2Capecitabine 2Biopsy 2Vorinostat 1Specimen Handling 1Polymerase Chain Reaction 1Platinum 1Octreotide 1Observation 1Mitozytrex 1Magnetic Resonance Spectroscopy 1Laser Therapy 1Imiquimod 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1DNA Methylation 1Cidofovir 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Anus Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT04166318 2026-05-05

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
252 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡